| Financial Year |
March 31 2023 |
| Monetary Funds |
24,770,521,629.20 |
| Held-for-trading Financial Assets |
340,914,873.12 |
| Notes Receivable |
4,052,317,709.86 |
| Accounts Receivable |
142,045,273,728.78 |
| Advances to Suppliers |
2,783,699,295.94 |
| Other Receivables |
9,837,347,814.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
767,696.84 |
| Inventories |
3,275,163,399.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
23,314,700.00 |
| Other Current Assets |
2,608,807,589.26 |
| Total Current Assets |
267,509,012,762.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,910,549,677.23 |
| Long-term Equity Investment |
1,600,545,789.91 |
| Investment Properties |
1,242,944,016.95 |
| Fixed Assetes |
3,217,981,837.83 |
| Under-construction Projects |
1,143,607,591.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,296,012,845.41 |
| R&D expenses |
-- |
| Goodwill |
26,537,295.42 |
| Long-Term Deferred and Prepaid Expenses |
497,107,614.70 |
| Deferred Income Tax Assets |
2,967,947,205.54 |
| Other Non-Current Assets |
7,417,732,361.69 |
| Sub-Total of Non-Current Assets |
38,687,365,482.34 |
| Total Assets |
306,196,378,244.94 |
| Short-Term Loans |
12,017,894,753.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,266,343,622.23 |
| Accounts Payable |
161,915,246,192.90 |
| Accounts Received In Advance |
4,679,037.99 |
| Employee Compensation Payable |
1,696,023,198.83 |
| Taxes Payable |
2,177,418,297.01 |
| Interest Payable |
-- |
| Dividend Payable |
12,845,017.95 |
| Other payables |
16,308,850,381.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,639,522,049.12 |
| Other Current Liabilities |
12,451,463,444.76 |
| Sub-Total of Current Liabilities |
250,148,461,106.87 |
| Long-term Loans |
18,139,025,336.85 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
55,050,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
867,676,758.91 |
| Deferred Income Tax Liabilities |
19,430,290.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,275,349,786.31 |
| Total Liabilities |
270,423,810,893.18 |
| Paid-In Capital(Or Share Stock) |
3,688,882,286.00 |
| Capital Surplus |
1,875,824,173.19 |
| Surplus Reserve |
213,816,909.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
12,013,077,237.42 |
| Minority Stockholder's Interest |
11,353,236,751.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,419,330,600.15 |
| Owner's Equity（Stockholder's Equity） |
35,772,567,351.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
306,196,378,244.94 |
